Home > HSE data management and performance profile reports 2023.

Health Service Executive. (2024) HSE data management and performance profile reports 2023. Dublin: Health Service Executive.

[img]
Preview
PDF (Data management report August 2023) - Published Version
3MB
[img]
Preview
PDF (Performance profile July - September 2023) - Published Version
2MB
[img]
Preview
PDF (Data management report September 2023) - Published Version
2MB
[img]
Preview
PDF (Data management report July 2023) - Published Version
1MB
[img]
Preview
PDF (Data management report June 2023)
2MB
[img]
Preview
PDF (Performance profile April - June 2023)
2MB
[img]
Preview
PDF (Data management report March 2023)
2MB
[img]
Preview
PDF (Performance profile January - March 2023)
2MB

Data management report: August 2023

P.113 Opioid substitution

  • Total no. of clients in receipt of opioid substitution treatment (outside prisons)
  • Average waiting time from referral to assessment for opioid substitution treatment (days)
  • Average waiting time from opioid substitution assessment to exit from waiting list or treatment commenced (days)

Performance profile July – September 2023

P.29 Social inclusion

  • % of substance misusers (over 18 years) for whom treatment has commenced within one calendar month following assessment
  • %. of substance misusers (under 18 years) for whom treatment has commenced within one week following assessment
  • % of service users admitted to homeless emergency accommodation hostels / facilities whose health needs have been assessed within two weeks of admission

P.27 Health and Wellbeing - Tobacco

  • Number of smokers who received intensive cessation support
  • % of smokers on cessation programmes who were quit at four weeks

____________________________________________

Data management report for June 2023

P.120 Opioid Substitution

  • Total no. of clients in receipt of opioid substitution treatment (outside prisons)
  • Average waiting time from referral to assessment for opioid substitution treatment (days)
  • Average waiting time from opioid substitution assessment to exit from waiting list or treatment commenced (days)
  • Needle Exchange - No of unique individuals attending the Pharmacy Needle Exchange Programme 

P.122 Substance misuse

  • No. of substance misusers (over 18) for whom treatment has commenced within one calendar month following assessment
  • % of substance misusers (over 18 years) for whom treatment has commenced within one calendar month following assessment
  • No. of substance misusers (under 18 years) for whom treatment has commenced within one week following assessment
  • % of substance misusers (under 18 years) for whom treatment has commenced within one week following assessment

Performance profile April – June 2023

P.41 Social Inclusion - data includes:

  • % of substance misusers (over 18 years) for whom treatment has commenced within one calendar month following assessment
  • %. of substance misusers (under 18 years) for whom treatment has commenced within one week following assessment
  • % of service users admitted to homeless emergency accommodation hostels / facilities whose health needs have been assessed within two weeks of admission

P. 60 Opioid substitution - Social inclusion continues to operate at similar levels to 2022. The total number of clients in receipt of opioid substitution treatment (outside prisons) as of the end of May was 10,585 and is -1.8% below the expected activity level of 10,784(SI1)

Needle Exchange - The number of unique individuals attending the Pharmacy Needle Exchange Programme at the end of March 2023 (data quarterly in arrears) was 1,461 which represents a decrease of -2.6% in expected activity (1,500) and -7.9% behind the same period last year position of 1,586. 

P.19 Health and Wellbeing - Tobacco

  • Number of smokers who received intensive cessation support
  • % of smokers on cessation programmes who were quit at four weeks

Number of smokers who received intensive cessation support - % of smokers on cessation programmes who were quit at four weeks Nationally, 5,454 smokers received intensive cessation support from a cessation counsellor YTD to March 2023 (this metric is reported quarterly in arrears), which is just -8.1% below the target of 5,935 smokers (HWB27). CHOs 1 and 3 have exceeded their targets. Underperformance is noted within CHOs 2 (-18.6%), 4 (-17.5%), 5 (-36.3%), 6 (-61.7%), 7 (-35.2%), 8 (-35.1%) & 9 (-37.6%) as well as within the RCSI (-10.3%), UL (-100%) and Saolta (-72.6%) Hospital Groups. UL & Saolta Hospital Groups continued to have staff vacancies for Q1. The National Quitline continued to perform well in Q1 with (+48.8%) of annual target achieved in Q1.

Online Cessation Support Services - 4,386 (+26%) people received online cessation support services to the end of Q2 2023 (HWB101) i.e. signed up for and subsequently activated a QUIT Plan on www.quit.ie. There was strong performance in online activity and traffic to www.quit.ie throughout Q2 2023 as a result of our new media campaign ‘Take Back Control’, which launched in January across TV/Radio/Social. 

______________________________________________________________

Repository Staff Only: item control page